FI972332A0 - Verisuonitukoksia estävä uusi formulaatio, menetelmä sen valmistamiseksi ja sen käyttö - Google Patents

Verisuonitukoksia estävä uusi formulaatio, menetelmä sen valmistamiseksi ja sen käyttö

Info

Publication number
FI972332A0
FI972332A0 FI972332A FI972332A FI972332A0 FI 972332 A0 FI972332 A0 FI 972332A0 FI 972332 A FI972332 A FI 972332A FI 972332 A FI972332 A FI 972332A FI 972332 A0 FI972332 A0 FI 972332A0
Authority
FI
Finland
Prior art keywords
preparation
new antithrombotic
formulation
antithrombotic formulation
new
Prior art date
Application number
FI972332A
Other languages
English (en)
Swedish (sv)
Other versions
FI972332A (fi
Inventor
Jan-Erik Loefroth
Anna-Lena Ungell
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI972332A0 publication Critical patent/FI972332A0/fi
Publication of FI972332A publication Critical patent/FI972332A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
FI972332A 1994-12-02 1997-06-02 Verisuonitukoksia estävä uusi formulaatio, menetelmä sen valmistamiseksi ja sen käyttö FI972332A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9404196A SE9404196D0 (sv) 1994-12-02 1994-12-02 New antithrombotic formulation
PCT/SE1995/001425 WO1996016671A1 (en) 1994-12-02 1995-11-29 New antithrombotic formulation, process for its manufacturing, and use thereof

Publications (2)

Publication Number Publication Date
FI972332A0 true FI972332A0 (fi) 1997-06-02
FI972332A FI972332A (fi) 1997-06-02

Family

ID=20396207

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972332A FI972332A (fi) 1994-12-02 1997-06-02 Verisuonitukoksia estävä uusi formulaatio, menetelmä sen valmistamiseksi ja sen käyttö

Country Status (27)

Country Link
US (1) US5795896A (fi)
EP (1) EP0799052B1 (fi)
JP (1) JPH10513438A (fi)
CN (1) CN1168635A (fi)
AR (1) AR002254A1 (fi)
AT (1) ATE208628T1 (fi)
AU (1) AU689994B2 (fi)
BR (1) BR9509853A (fi)
CA (1) CA2206459A1 (fi)
CZ (1) CZ147097A3 (fi)
DE (1) DE69523943T2 (fi)
DK (1) DK0799052T3 (fi)
EE (1) EE03338B1 (fi)
ES (1) ES2168395T3 (fi)
FI (1) FI972332A (fi)
HU (1) HU216631B (fi)
IL (1) IL116153A (fi)
IS (1) IS4483A (fi)
NO (1) NO972475D0 (fi)
NZ (1) NZ297118A (fi)
PL (1) PL320692A1 (fi)
PT (1) PT799052E (fi)
SE (1) SE9404196D0 (fi)
SK (1) SK61797A3 (fi)
TR (1) TR199501517A2 (fi)
WO (1) WO1996016671A1 (fi)
ZA (1) ZA9510242B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US6984627B1 (en) * 1993-06-03 2006-01-10 Astrazeneca Ab Peptide derivatives
GB9526273D0 (en) * 1995-12-21 1996-02-21 Astra Ab New prodrugs
TWI238827B (en) * 1995-12-21 2005-09-01 Astrazeneca Ab Prodrugs of thrombin inhibitors
SE9602145D0 (sv) * 1996-05-31 1996-05-31 Astra Ab New improved formulation for treatment of thromboembolism
US6423334B1 (en) * 1997-10-01 2002-07-23 Elan Corporation, Plc Composition and method for enhancing transport across gastrointestinal tract cell layers
AR023510A1 (es) * 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
AR023819A1 (es) 1999-05-03 2002-09-04 Astrazeneca Ab FORMULACIoN FARMACEUTICA, KIT DE PARTES Y UTILIZACION DE DICHA FORMULACION
SE9902550D0 (sv) * 1999-07-02 1999-07-02 Astra Ab New crystalline forms
SE9904377D0 (sv) * 1999-12-01 1999-12-01 Astra Pharma Prod Pharmaceutical combinations
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
KR100994221B1 (ko) 2001-06-14 2010-11-12 오츠카 세이야쿠 가부시키가이샤 의약 조성물
SE0103590D0 (sv) * 2001-10-26 2001-10-26 Astrazeneca Ab New Combination
SE0203349D0 (sv) * 2002-11-12 2002-11-12 Astrazeneca Ab New use
CN100513398C (zh) 2002-12-03 2009-07-15 Axys药物公司 作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物
US7345093B2 (en) * 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US8268791B2 (en) * 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
US20090047347A1 (en) * 2005-07-29 2009-02-19 Aegis Therapeutics, Inc. Compositions for Drug Administration
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
RU2354647C2 (ru) 2007-06-28 2009-05-10 Общество С Ограниченной Ответственностью "Бионика" Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе
DK2271347T3 (en) * 2008-03-28 2016-08-15 Hale Biopharma Ventures Llc Administration of benzodiazepine compositions
US8541360B2 (en) * 2008-11-19 2013-09-24 Ben Venue Laboratories, Inc. Parenteral formulations comprising sugar-based esters and ethers
US8440631B2 (en) * 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
US20100215730A1 (en) * 2009-02-20 2010-08-26 Intrepid Therapeutics, Inc. Compositions for Nasal Administration of Phenothiazines
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
WO2011038068A1 (en) 2009-09-23 2011-03-31 Formatech, Inc. Methods for the preparation of liposomes
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes
PL3415139T3 (pl) 2011-06-14 2022-07-11 Neurelis, Inc. Podawanie benzodiazepiny
JP6941224B2 (ja) 2018-02-06 2021-09-29 イージス セラピューティクス，エルエルシー 疾患の処置のための鼻腔内エピネフリン製剤及び方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
US4568636A (en) * 1981-03-25 1986-02-04 Pentapharm Ag Tripeptide derivatives
US4395401A (en) * 1981-09-09 1983-07-26 Smithkline Beckman Corporation Renally active dipeptides
HU192646B (en) * 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
ZA86746B (en) * 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
DE3505555A1 (de) * 1985-02-18 1986-09-11 Behringwerke Ag, 3550 Marburg Neue oligopeptidylargininolderivate und deren homologe, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel
PT84170B (pt) * 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados n alfa-substituidos das n alfa-aril-sulfonilaminoacil d-amidinofenil-alaninamidas
DE3606480A1 (de) * 1986-02-28 1987-09-03 Behringwerke Ag Oligopeptidylnitrilderivate, diese enthaltende mittel, verfahren zu ihrer herstellung und ihre verwendung
US5187157A (en) * 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0362002B1 (en) * 1988-09-01 1995-07-26 Merrell Dow Pharmaceuticals Inc. HIV protease inhibitors
ZA897515B (en) * 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
US5053392A (en) * 1989-12-01 1991-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Novel arginine, glycine, aspartic acid derivatives as platelet-aggregation inhibitors
US5110812A (en) * 1990-06-04 1992-05-05 Bristol-Myers Squibb Co. Azetidin-2-one derivatives as serine protease inhibitors
US5037819A (en) * 1990-06-04 1991-08-06 Bristol-Myers Squibb Company Azetidin-2-one derivatives as serine protease inhibitors
TW201303B (fi) * 1990-07-05 1993-03-01 Hoffmann La Roche
GB9017694D0 (en) * 1990-08-13 1990-09-26 Sandoz Ltd Improvements in or relating to organic chemistry
GB9019558D0 (en) * 1990-09-07 1990-10-24 Szelke Michael Enzyme inhibitors
IL99527A (en) * 1990-09-28 1997-08-14 Lilly Co Eli Tripeptide antithrombotic agents
GB9024129D0 (en) * 1990-11-06 1990-12-19 Thrombosis Research Trust Inhibitors and substrates of thrombin
KR920703558A (ko) * 1990-11-15 1992-12-18 원본미기재 메타-치환 페닐알라닌 유도체
DE4115468A1 (de) * 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
SE9102462D0 (sv) * 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
ZA928581B (en) * 1991-11-12 1994-05-06 Lilly Co Eli Antithrombotic agents
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives

Also Published As

Publication number Publication date
NZ297118A (en) 1998-12-23
IS4483A (is) 1997-05-16
SE9404196D0 (sv) 1994-12-02
NO972475L (no) 1997-05-30
DE69523943D1 (de) 2001-12-20
IL116153A0 (en) 1996-01-31
CZ147097A3 (cs) 1998-02-18
NO972475D0 (no) 1997-05-30
DE69523943T2 (de) 2002-06-27
EP0799052A1 (en) 1997-10-08
EP0799052B1 (en) 2001-11-14
ATE208628T1 (de) 2001-11-15
WO1996016671A1 (en) 1996-06-06
EE03338B1 (et) 2001-02-15
AU689994B2 (en) 1998-04-09
ES2168395T3 (es) 2002-06-16
HUT77655A (hu) 1998-07-28
SK61797A3 (en) 1998-03-04
JPH10513438A (ja) 1998-12-22
AU4191596A (en) 1996-06-19
IL116153A (en) 1999-11-30
DK0799052T3 (da) 2002-02-25
HU216631B (hu) 1999-07-28
CA2206459A1 (en) 1996-06-06
PL320692A1 (en) 1997-10-27
BR9509853A (pt) 1997-12-30
TR199501517A2 (tr) 1996-07-21
AR002254A1 (es) 1998-03-11
US5795896A (en) 1998-08-18
MX9703975A (es) 1997-09-30
PT799052E (pt) 2002-05-31
CN1168635A (zh) 1997-12-24
FI972332A (fi) 1997-06-02
ZA9510242B (en) 1996-06-03

Similar Documents

Publication Publication Date Title
FI972332A (fi) Verisuonitukoksia estävä uusi formulaatio, menetelmä sen valmistamiseksi ja sen käyttö
FI971354A0 (fi) Antineoplastiset kaakaouutteet, niiden valmistusmenetelmät ja käyttö
FI955235A (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
FI971969A (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
FI955362A0 (fi) Symmetrointilaite ja menetelmä sen suunnittelemiseksi
FI955051A (fi) Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
FR2744442B1 (fr) Preparation du 1,1,1,3,3-pentachlorobutane et du 1,1,1,3,3,-pentafluorobutane
FI972245A (fi) Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät
FI962908A (fi) Mikrobinvastainen koostumus, sen valmistusmenetelmä ja sen käyttö
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
FI972306A (fi) Substituoituja 2-aryylikarbonyylioksimetyyli-1,2,5-tiadiatsolidin -3- oni-1,1-dioksidi-johdannaisia ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
NO973826D0 (no) Ny anvendelse av preparater inneholdende perlemor
FI941914A0 (fi) 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö
DE69524976T2 (de) Herstellung von [11C] Methyljodid
FI970103A0 (fi) Mikro-organismeja sisältävä raekoostumus, menetelmä sen valmistamiseksi ja sen käyttö
FI944842A0 (fi) Fluoratut 4-aminoandrostadienonijohdannaiset ja menetelmä niiden valmistamiseksi
EE03687B1 (et) Furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
FI972464A (fi) Diaminoeetterin diklavulanaattisuola ja menetelmä sen valmistamiseksi
FI956251A0 (fi) 1-okso-2-(fenyylisulfonyyliamino)pentyylipiperidiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI894323A0 (fi) Antimikrobiaalinen ainekoostumus, menetelmä ja käyttö
EE03796B1 (et) 3,5-difluoropüridiinid, nende valmistamismeetod, herbitsiidne kompositsioon, nende kasutamine ja vaheühend
FR2723377B1 (fr) Compositions nettoyantes ou decapantes, et preparations les contenant
FI970098A0 (fi) Menetelmä ja yhdiste hiustenlähdön hoitamiseksi
FR2733230B1 (fr) Nouveaux derives d'ornithine, procede de preparation, utilisation et composition les comprenant
IL115441A0 (en) Phenyl ether derivatives their preparation and use